Identification of NQO2 As a Protein Target in Small Molecule Modulation of Hepatocellular Function.

The utility of human disease models is mainly dependent on the availability and functional maturity of tissue-specific cell types. We have previously screened for and identified small molecules that can enhance hepatocyte function . Here, we characterize the functional effects of one of the hits, FH1, on primary human hepatocytes , and also on primary hepatocytes in a zebrafish model. Furthermore, we conducted an analogue screen to establish the structure-activity relationship of FH1. We performed affinity-purification proteomics that identified NQO2 to be a potential binding target for this small molecule, revealing a possible link between inflammatory signaling and hepatocellular function in zebrafish and human hepatocyte model systems.